Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis

Chayama K, Suzuki F, Karino Y, et al. Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis. J Gastroenterol. 2018;53(4):557-565.

Publication Type:

Journal Article

Authors:

Chayama, K; Suzuki, F.; Karino, Y; et, al

Source:

J Gastroenterol, Volume 53, Issue 4, p.557-565 (2018)

Cited On:

Treatment-Naive Genotype 1b Without Cirrhosis

Export Citation:

RIS Format

Top